Current Understanding and Future Perspectives on Hyperprogressive Disease Highlight the Tumor Microenvironment.

Area of Science:

• Oncology
• Immunology
• Cancer Research

Background:

• Cancer immunotherapy using immune checkpoint inhibitors has transformed cancer treatment.
• While beneficial for many, some patients exhibit hyperprogressive disease (HPD) with rapid tumor growth post-treatment.

Purpose of the Study:

• To review current knowledge on hyperprogressive disease (HPD) following immune checkpoint inhibitor therapy.
• To enhance understanding of HPD, focusing on the tumor microenvironment.

Main Methods:

• Literature review of studies on cancer immunotherapy and HPD.
• Analysis of factors contributing to HPD, with emphasis on the tumor microenvironment.

Main Results:

• HPD represents a significant challenge in cancer immunotherapy.
• The tumor microenvironment plays a crucial role in HPD development.

Conclusions:

• Further research into HPD biomarkers and therapeutics is essential.
• A deeper understanding of HPD mechanisms, particularly the tumor microenvironment, is needed to improve patient outcomes.